Aveanna Healthcare Holdings, Inc. (AVAH) financials: revenue, earnings and cash flow
Fiscal 2019–2025 + TTM · from SEC filings · data as of November 16, 2026
Summary
Aveanna Healthcare’s revenue went from $1.4B in fiscal 2019 to $2.4B in fiscal 2025, growth of about 9.9% a year.
Net income in fiscal 2025 was $225M, a net margin of 9.2%; the highest of the period.
Over the twelve months to October 3, 2026, revenue was $2.7B and net income $306M.
The diluted share count fell 100% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.7B | $2.4B | $2.0B | $1.9B | $1.8B | $1.7B | $1.5B | $1.4B |
| Gross profit | $864M | $810M | $636M | $595M | $553M | $542M | $455M | $419M |
| Operating income | $304M | $256M | $140M | $8M | -$642M | -$36M | -$3M | $39M |
| Net income | $306M | $225M | -$11M | -$135M | -$662M | -$117M | -$57M | -$77M |
| EPS (diluted) | $1.40 | $1.05 | $-0.06 | $-0.71 | $-3.57 | $-0.00 | $-0.00 | $-0.00 |
| R&D | — | — | — | — | — | — | — | — |
| Revenue growth | — | +20.2% | +6.8% | +6.0% | +6.5% | +12.3% | +8.0% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $207M | $126M | $33M | $23M | -$48M | -$11M | $117M | -$9M |
| Capital spending | -$10M | — | — | — | — | -$16M | -$15M | -$17M |
| Free cash flow | $198M | — | — | — | — | -$27M | $101M | -$25M |
| Dividends paid | — | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Buybacks | — | — | — | — | — | — | — | — |
| Stock-based pay | $16M | $25M | $17M | $13M | $16M | $14M | $3M | $2M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash | — | $193M | $84M | $44M | $19M | $30M | $137M | — |
| Debt | — | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | — |
| Equity | — | $194M | -$124M | -$130M | -$6M | $636M | $265M | $270M |
| Total assets | — | $2.0B | $1.7B | $1.6B | $1.7B | $2.3B | $1.8B | — |
| Shares (diluted) | 229M | 215M | 193M | 190M | 186M | 171M | 140.97B | 136.91B |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 32.3% | 33.3% | 31.4% | 31.4% | 30.9% | 32.3% | 30.4% | 30.3% |
| Operating margin | 11.4% | 10.5% | 6.9% | 0.4% | -35.9% | -2.1% | -0.2% | 2.8% |
| Net margin | 11.4% | 9.2% | -0.5% | -7.1% | -37.0% | -7.0% | -3.8% | -5.5% |
| FCF margin | 7.4% | — | — | — | — | -1.6% | 6.8% | -1.8% |
| ROIC | — | 13.2% | 9.2% | 0.7% | -47.7% | -1.5% | -0.2% | 11.4% |
| ROE | — | 115.7% | 8.8% | 103.8% | 10491.8% | -18.4% | -21.5% | -28.3% |
Frequently asked questions
What is Aveanna Healthcare’s annual revenue?
$2.4B in fiscal 2025 and $2.7B over the twelve months to October 3, 2026.
How much profit does Aveanna Healthcare make?
Net income was $225M in fiscal 2025 (net margin 9.2%).
Is Aveanna Healthcare’s revenue growing?
Yes: revenue rose 20.2% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.